BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37599238)

  • 21. [Application of gastric pull up and complex laryngotracheal flap to reconstruct the circumferencial defect after resection of the hypopharyngeal and cervical esophageal cancers].
    Li SC; Li ZD; Liu HW; Xu CJ; Zeng W; Dong HL; Lu T
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Sep; 53(9):661-667. PubMed ID: 30293257
    [No Abstract]   [Full Text] [Related]  

  • 22. Patients with locally advanced hypopharyngeal carcinoma. Results over a 30-year period.
    León X; López M; García J; Rovira C; Casasayas M; Quer M
    Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(6):315-326. PubMed ID: 30527320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical study of postoperative adjuvant radiotherapy and postoperative concurrent chemoradiotherapy for locally advanced hypopharyngeal squamous cell carcinoma].
    Liu K; Zhang XX; Liu MB; Wang JL; Wu WM; Huang DL; Zhao JD; Ma L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Sep; 54(9):662-669. PubMed ID: 31550757
    [No Abstract]   [Full Text] [Related]  

  • 24. [Laryngeal function preserving surgery in hypopharyngeal carcinoma].
    Li JX; Li XR; Sun G; Qu B; Wang H; Dai S; Guo ZX
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jun; 44(6):469-74. PubMed ID: 19954017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of regional lymph node failure of locally advanced hypopharyngeal squamous cell carcinoma after first-line treatment with surgery and/or intensity-modulated radiotherapy.
    Wang D; Yu S; Zhai L; Xu J; Li B
    BMC Cancer; 2020 Apr; 20(1):283. PubMed ID: 32252691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changing trend in prognosis of primary hypopharyngeal carcinoma and reason analysis: date comparison of 2003-2007 and 2010-2014 in a single centre].
    Tao L; Zhou L; Zhang M; Wu HT; Li XM; Chen XL; Li C; Xie M; Cheng L; Heng Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Feb; 55(2):116-124. PubMed ID: 32074749
    [No Abstract]   [Full Text] [Related]  

  • 27. [Laryngo-tracheal flap to reconstruct the defect after resection of the hypopharyngeal carcinoma with cervical esophagus involvement].
    Li W; Yang L; Chen M; Zhu J; Yuan L; Gu D
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Dec; 28(24):1945-8. PubMed ID: 25895312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective analysis of the clinical efficacy of definitive chemoradiotherapy for patients with hypopharyngeal cancer.
    Takehana K; Kodaira T; Tachibana H; Kimura K; Shimizu A; Makita C; Tomita N; Nishikawa D; Suzuki H; Hirakawa H; Hanai N; Hasegawa Y
    Jpn J Clin Oncol; 2016 Apr; 46(4):344-9. PubMed ID: 26826721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nutritional status and feeding-tube placement in patients with locally advanced hypopharyngeal cancer included in an induction chemotherapy-based larynx preservation program.
    Bozec A; Benezery K; Chamorey E; Ettaiche M; Vandersteen C; Dassonville O; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Sudaka A; Haudebourg J; Hebert C; Falewee MN; Demard F; Santini J; Peyrade F
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2681-7. PubMed ID: 26395117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.
    Li L; Chen L; Yan L; Guo Y; Li F; Fan M; Lan M; Lai X; Zhou J; Huang Y; Xu P; Lang J; Feng M
    Radiat Oncol; 2023 Jul; 18(1):109. PubMed ID: 37403098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy evaluation of different measurement methods for target lesions after neoadjuvant chemotherapy and radical radiotherapy in locally advanced hypopharyngeal carcinoma.
    Hou FJ; Zhao D; Yan XY; Li XT; Sun Y; Sun YS; Gao SY
    Asia Pac J Clin Oncol; 2023 Feb; 19(1):187-195. PubMed ID: 35692104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy and influencing factors of immunotherapy combined with chemotherapy and bevacizumab in patients with non-small cell lung cancer after epidermal growth factor receptor tyrosine kinase inhibitors treatment failure].
    Wang C; Li Y; Guan Y; Yang SJ; Yin JC; Zhang CF; Guo QS; Shi WN
    Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(16):1210-1216. PubMed ID: 37087404
    [No Abstract]   [Full Text] [Related]  

  • 34. Induction chemotherapy for the individualised treatment of hypopharyngeal carcinoma with cervical oesophageal invasion: a retrospective cohort study.
    Huang TQ; Wang R; Fang JG; He SZ; Zhong Q; Hou LZ; Ma HZ; Chen XH; Chen XJ; Li PD; Feng L; Shi Q; Lian M
    World J Surg Oncol; 2020 Dec; 18(1):330. PubMed ID: 33308220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of vascular changes on prognosis after induced chemotherapy for advanced hypopharyngeal carcinoma].
    Guo W; Yin GF; Huang JW; Yang Z; Liu HF; Zhang Y; Xu HB; Liu ZY; Huang ZG
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Aug; 54(8):591-596. PubMed ID: 31434372
    [No Abstract]   [Full Text] [Related]  

  • 36. Intensity modulated radiotherapy with concurrent chemotherapy for larynx preservation of advanced resectable hypopharyngeal cancer.
    Huang WY; Jen YM; Chen CM; Su YF; Lin CS; Lin YS; Chang YN; Chao HL; Lin KT; Chang LP
    Radiat Oncol; 2010 May; 5():37. PubMed ID: 20470428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [An attempt to evaluate prognosis in cases of metastasis from laryngeal and hypopharyngeal carcinoma to cervical lymph nodes].
    Sieczka JP
    Ann Acad Med Stetin; 1996; 42():157-76. PubMed ID: 9199119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
    Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The impact of surgical treatment on the life quality of patients with locally advanced hypopharyngeal carcinoma].
    Ma H; Wang XL; Wei MH; An CM
    Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):687-691. PubMed ID: 32867463
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction TPF followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locally advanced hypopharyngeal cancer: a preliminary analysis of a randomized phase 2 trial.
    Luo X; Huang X; Luo J; Xiao J; Wang K; Qu Y; Chen X; Zhang Y; Wu R; Wang J; Zhang J; Xu G; Gao L; Liu S; Wang X; He X; Luo D; Yi J
    BMC Cancer; 2022 Nov; 22(1):1235. PubMed ID: 36447152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.